Page last updated: 2024-10-29

indirubin-3'-monoxime and Mouth Neoplasms

indirubin-3'-monoxime has been researched along with Mouth Neoplasms in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Mouth Neoplasms: Tumors or cancer of the MOUTH.

Research Excerpts

ExcerptRelevanceReference
"Using an oral cancer mouse model, we demonstrate that topical application of an adhesive gel composed of I3M and poly(vinyl alcohol) (I3M/PVA) has dose-dependent anti-tumorigenic effects."1.39An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. ( Chang, NW; Lo, WY, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lo, WY1
Chang, NW1

Other Studies

1 other study available for indirubin-3'-monoxime and Mouth Neoplasms

ArticleYear
An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement;

2013